These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 18222975
1. Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro. Zou XJ, Yang L, Yao SL. Exp Biol Med (Maywood); 2008 Feb; 233(2):200-8. PubMed ID: 18222975 [Abstract] [Full Text] [Related]
3. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway. Li H, Tan J, Zou Z, Huang CG, Shi XY. Eur J Anaesthesiol; 2011 Jul; 28(7):525-34. PubMed ID: 21666544 [Abstract] [Full Text] [Related]
4. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Hingtgen SD, Tian X, Yang J, Dunlay SM, Peek AS, Wu Y, Sharma RV, Engelhardt JF, Davisson RL. Physiol Genomics; 2006 Aug 16; 26(3):180-91. PubMed ID: 16670255 [Abstract] [Full Text] [Related]
11. Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation. Zhao Z, Wang W, Geng J, Wang L, Su G, Zhang Y, Ge Z, Kang W. J Cell Biochem; 2010 Mar 01; 109(4):653-62. PubMed ID: 20052676 [Abstract] [Full Text] [Related]
13. Nuclear factor-kappaB signaling contributes to severe, but not moderate, angiotensin II-induced left ventricular remodeling. Sármán B, Skoumal R, Leskinen H, Rysä J, Ilves M, Soini Y, Tuukkanen J, Pikkarainen S, Lakó-Futó Z, Sármán B, Papp L, deChâtel R, Tóth M, Ruskoaho H, Szokodi I. J Hypertens; 2007 Sep 01; 25(9):1927-39. PubMed ID: 17762659 [Abstract] [Full Text] [Related]
14. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy. Kashiwase K, Higuchi Y, Hirotani S, Yamaguchi O, Hikoso S, Takeda T, Watanabe T, Taniike M, Nakai A, Tsujimoto I, Matsumura Y, Ueno H, Nishida K, Hori M, Otsu K. Biochem Biophys Res Commun; 2005 Feb 04; 327(1):136-42. PubMed ID: 15629441 [Abstract] [Full Text] [Related]
16. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Morikawa-Futamatsu K, Adachi S, Maejima Y, Tamamori-Adachi M, Suzuki J, Kitajima S, Ito H, Isobe M. Life Sci; 2006 Aug 29; 79(14):1380-90. PubMed ID: 16712874 [Abstract] [Full Text] [Related]
17. [Effects of tetrandrine on Ang II-induced cardiomyocyte hypertrophy and p-ERK1/2 expression]. Zhou DX, Yang GT, He XX, Liu Q. Zhongguo Zhong Yao Za Zhi; 2007 Sep 29; 32(18):1921-4. PubMed ID: 18051908 [Abstract] [Full Text] [Related]
18. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1. Hayashi D, Kudoh S, Shiojima I, Zou Y, Harada K, Shimoyama M, Imai Y, Monzen K, Yamazaki T, Yazaki Y, Nagai R, Komuro I. Biochem Biophys Res Commun; 2004 Sep 10; 322(1):310-9. PubMed ID: 15313208 [Abstract] [Full Text] [Related]
19. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes. Qin J, Liu ZX. Acta Pharmacol Sin; 2006 Sep 10; 27(9):1159-64. PubMed ID: 16923336 [Abstract] [Full Text] [Related]